Biotech · Private company
Medy-Tox
Track this companyFree. Adds Medy-Tox to your Dealase workspace and tells you when its record changes.
Clinical trials50 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- MT10109LPhase 3 · Glabellar LinesClinicalTrials.gov · fetched Nov 12, 2026
- MT10109LPhase 3 · Lateral Canthal LinesClinicalTrials.gov · fetched Nov 12, 2026
- MT10109L Dose 1Phase 3 · Glabellar LinesClinicalTrials.gov · fetched Nov 12, 2026
- MT10109L Dose 1 + Dose 2Phase 3 · Glabellar LinesClinicalTrials.gov · fetched Nov 12, 2026
- MT10109L Dose 2Phase 3 · Glabellar LinesClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- MT10109L in the Long-term, Open-label Treatment of Glabellar Lines (GL) and Lateral Canthal Lines (LCL)PHASE3 · COMPLETED · started Oct 23, 2019ClinicalTrials.gov NCT04157686 · fetched Nov 12, 2026
- MT10109L in the Treatment of Glabellar LinesPHASE3 · COMPLETED · started Dec 24, 2018ClinicalTrials.gov NCT03795922 · fetched Nov 12, 2026
- MT10109L in the Treatment of Lateral Canthal LinesPHASE3 · COMPLETED · started Dec 20, 2018ClinicalTrials.gov NCT03785145 · fetched Nov 12, 2026
- MT10109L in the Treatment of Lateral Canthal Lines With or Without Concurrent Treatment of Glabellar LinesPHASE3 · COMPLETED · started Nov 5, 2018ClinicalTrials.gov NCT03732833 · fetched Nov 12, 2026
- MT10109L in the Treatment of Glabellar Lines (GL) With or Without Concurrent Treatment of Lateral Canthal Lines (LCL)PHASE3 · COMPLETED · started Oct 26, 2018ClinicalTrials.gov NCT03721016 · fetched Nov 12, 2026